Janus Henderson Group PLC Raises Stock Position in Avantor, Inc. (NYSE:AVTR)

Janus Henderson Group PLC lifted its position in Avantor, Inc. (NYSE:AVTR) by 18.2% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 17,692,705 shares of the company’s stock after buying an additional 2,719,615 shares during the period. Janus Henderson Group PLC owned approximately 2.60% of Avantor worth $457,710,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Versant Capital Management Inc lifted its position in Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after buying an additional 1,102 shares during the last quarter. Blue Trust Inc. lifted its holdings in Avantor by 1,830.3% in the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock valued at $31,000 after purchasing an additional 1,391 shares in the last quarter. UMB Bank n.a. acquired a new stake in Avantor during the 3rd quarter worth approximately $49,000. Nisa Investment Advisors LLC boosted its stake in shares of Avantor by 69.6% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after buying an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC lifted its stake in Avantor by 89.9% during the third quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock worth $70,000 after purchasing an additional 1,285 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling at Avantor

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the business’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total value of $88,336.50. Following the completion of the sale, the chief accounting officer now owns 29,544 shares of the company’s stock, valued at $740,372.64. The trade was a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

Avantor Stock Performance

Shares of AVTR opened at $21.09 on Tuesday. The firm has a market cap of $14.35 billion, a PE ratio of 45.85, a price-to-earnings-growth ratio of 2.55 and a beta of 1.29. Avantor, Inc. has a 12-month low of $19.59 and a 12-month high of $28.00. The company’s 50 day simple moving average is $23.28 and its 200-day simple moving average is $23.71. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on AVTR shares. Barclays cut their price objective on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, October 25th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 target price on shares of Avantor in a research report on Thursday, September 26th. UBS Group reduced their target price on Avantor from $30.00 to $29.00 and set a “buy” rating on the stock in a report on Tuesday, October 8th. Wells Fargo & Company decreased their price target on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. Finally, Robert W. Baird lowered their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. Three investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $27.57.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.